A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- li zhang
Sun Yat-sen University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, China
- Chongqing University Three Gorges Hospital
Chongqing, Chongqing Municipality, China
- the 900 Hospital of the Joint Service Support Force of the People'S Liberation Army of China
Fuzhou, Fujian, China
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
- the First People'S Hospital of Yu Lin
Yulin, Guangxi, China
- Henan Cancer Hospital
Zhengzhou, Henan, China
- Hubei Cancer Hospital
Wuhan, Hubei, China
- Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
- Hunan Cancer Hospital
Changsha, Hunan, China
- Changzhou Cancer Hospital
Changzhou, Jiangsu, China
- Qilu Hospital of Shandong University
Jinan, Shandong, China
- Affiliated Hospital of Jining Medical University
Jining, Shandong, China
- Linyi Cancer Hospital
Linyi, Shandong, China
- Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2021
- Primary completion
- 22 May 2024
- Completion
- 22 May 2024
- Last update posted
- 3 Jun 2025
- Registered enrollment
- 80
- Registry id
- NCT05102006
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.